This week's special holiday episode of the Business of Biotech brings seven chief editors from the Life Science Connect family together to talk about the life sciences industry topics, trips, and ...

Life sciences organizations are highly visible and active across established media channels, but discoverability represents ...

Biotech companies that will lead the next decade wont just have better science, theyll have superior operating models, writes ...

On this episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy spinouts from FujiFilm Cellular Dynamics, learning from big ...

Chris Smalley recently retired from Merck, where he had responsibility for innovative implementation and validation, including single-use systems, globally. Previously, he was director of quality ...

A versatile portfolio of catalytic continuous reaction processes has been developed to meet the diverse needs of the chemical and pharmaceutical industries. By leveraging flow chemistry, these ...

Lentiviral vectors (LVVs) play a critical role in genetic engineering strategies for CAR-T cell therapy, serving as the primary delivery vehicle for stable gene modification. Since the approval of ...

In recent years, China has undertaken substantial reforms of its regulatory framework governing Active Pharmaceutical Ingredients (APIs), bringing it into closer alignment with internationally ...

Service providers in the life sciences (e.g., CROs, CRMs, core labs, firms offering preclinical services such as formulation, etc) work in a sector that is changing, and changing rapidly. The 'Big ...

On this episode of the Business of Biotech, Jennifer Sheller, SVP and Head of Global Clinical Trial Operations at Merck talks about simplifying trial protocols and what she likes about Merck's hybrid ...

Understanding your microbial ecosystem can help you prevent leadership burnout. In a recent survey of several thousand senior leaders across the U.S., 72% reported being emotionally, physically, and ...

In the following article we introduce a case study as a framework for exploring critical study design considerations of gene therapy trials and offering strategies for addressing those hurdles. This ...